Cantor Fitzgerald has recently initiated Sellas Life Sciences Group Inc (SLS) stock to Overweight rating, as announced on July 21, 2021, according to Finviz. Earlier, on November 1, 2018, Oppenheimer ...

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on SELLAS Life Sciences Group (SLS – Research Report), retaining the price target ...

SELLAS Life Sciences Group ( (SLS) ) has issued an announcement.

Progressive Manufacturing Company (PMC) has become a Workhorse dealer, expanding the availability of electric commercial vehicles to specialized fleets.

Initiating the Interim Analysis – - REGAL Independent Data Monitoring Committee to Perform Interim Analysis in January 2025 - - Company to Host Webcast Call Today at 9:00 am ET NEW YORK, Dec. 10, 2024 ...

Not Yet Reached, Now Exceeds 7.7. Months at Latest Follow-Up in the 30 mg BIW Cohort in Patients Relapsed or Refractory to Venetoclax-Based Regimens - - Overall Response Rate (ORR) of 56% Achieved to ...

Cantor Fitzgerald has recently initiated Sellas Life Sciences Group Inc (SLS) stock to Overweight rating, as announced on July 21, 2021, according to Finviz. Earlier, on November 1, 2018, Oppenheimer ...

SELLAS has announced positive data from preclinical studies identifying the ASXL1 mutation as a predictor of response to ...

(RTTNews) - Sellas Life Sciences Group, Inc. (SLS), Wednesday announced positive data from preclinical studies identifying ASXL1 mutation as key predictor of SLS009, a highly selective CDK9 ...

Based on elucidated biology of ASXL1 mutations, results from SELLAS' clinical trials in acute myeloid leukemia (AML), and reports of common occurrence of ASXL1 mutations in some solid cancers, the ...